Counterfeit Drug Reporting: FDA Focuses On Numbers, Industry Worries About Process
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA revises estimate of annual drug counterfeit reports from 5,000 to 1,000; PhRMA wants manufacturers to play consulting role, while wholesale distributors say trading partner who discovered problem should provide sole notice.